Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
PPAR alpha | 16 | 2023 | 55 | 4.130 |
Why?
|
Hippocampus | 14 | 2023 | 262 | 2.560 |
Why?
|
Up-Regulation | 16 | 2022 | 150 | 2.440 |
Why?
|
Mice | 41 | 2023 | 1345 | 1.680 |
Why?
|
Animals | 47 | 2023 | 3510 | 1.450 |
Why?
|
Gene Expression Regulation | 8 | 2021 | 262 | 1.340 |
Why?
|
Memory | 6 | 2018 | 296 | 1.210 |
Why?
|
Dopaminergic Neurons | 8 | 2022 | 44 | 1.170 |
Why?
|
Parkinson Disease | 9 | 2020 | 776 | 1.120 |
Why?
|
Neurons | 13 | 2020 | 315 | 1.110 |
Why?
|
alpha-Synuclein | 5 | 2022 | 115 | 1.100 |
Why?
|
Disease Models, Animal | 16 | 2022 | 584 | 1.050 |
Why?
|
Mice, Inbred C57BL | 24 | 2023 | 405 | 1.000 |
Why?
|
Neuronal Plasticity | 5 | 2019 | 45 | 0.890 |
Why?
|
Oleic Acids | 2 | 2021 | 5 | 0.860 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 8 | 2019 | 34 | 0.860 |
Why?
|
Promoter Regions, Genetic | 4 | 2021 | 89 | 0.820 |
Why?
|
Signal Transduction | 9 | 2021 | 410 | 0.760 |
Why?
|
Substantia Nigra | 10 | 2022 | 111 | 0.760 |
Why?
|
Parkinsonian Disorders | 7 | 2021 | 210 | 0.750 |
Why?
|
Alzheimer Disease | 11 | 2023 | 1962 | 0.750 |
Why?
|
Sleep Aids, Pharmaceutical | 1 | 2021 | 2 | 0.730 |
Why?
|
Food Additives | 1 | 2021 | 7 | 0.720 |
Why?
|
Microglia | 8 | 2018 | 133 | 0.720 |
Why?
|
Sodium Chloride | 3 | 2014 | 32 | 0.660 |
Why?
|
Oxygen | 3 | 2014 | 74 | 0.650 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 5 | 2023 | 60 | 0.640 |
Why?
|
Nuclear Proteins | 2 | 2016 | 80 | 0.600 |
Why?
|
Nitric Oxide | 4 | 2013 | 75 | 0.600 |
Why?
|
Cinnamomum zeylanicum | 6 | 2020 | 22 | 0.590 |
Why?
|
Nerve Growth Factors | 2 | 2015 | 37 | 0.580 |
Why?
|
Simvastatin | 2 | 2015 | 14 | 0.580 |
Why?
|
Astrocytes | 5 | 2021 | 141 | 0.570 |
Why?
|
CD11b Antigen | 2 | 2008 | 14 | 0.570 |
Why?
|
Neuroglia | 4 | 2019 | 47 | 0.560 |
Why?
|
Hydroxybutyrates | 1 | 2016 | 7 | 0.540 |
Why?
|
Neurodegenerative Diseases | 5 | 2013 | 117 | 0.530 |
Why?
|
Basal Ganglia | 1 | 2016 | 15 | 0.520 |
Why?
|
Sodium Benzoate | 4 | 2019 | 19 | 0.520 |
Why?
|
Phenylbutyrates | 2 | 2013 | 7 | 0.510 |
Why?
|
Brain-Derived Neurotrophic Factor | 3 | 2020 | 46 | 0.480 |
Why?
|
Brain | 8 | 2021 | 1560 | 0.480 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 53 | 0.470 |
Why?
|
Synaptic Transmission | 1 | 2014 | 23 | 0.460 |
Why?
|
Aspirin | 3 | 2019 | 74 | 0.460 |
Why?
|
Gemfibrozil | 5 | 2021 | 29 | 0.460 |
Why?
|
Adipose Tissue | 1 | 2015 | 69 | 0.450 |
Why?
|
Interleukin-12 Subunit p40 | 3 | 2022 | 22 | 0.450 |
Why?
|
Ankyrin Repeat | 1 | 2013 | 2 | 0.440 |
Why?
|
Response Elements | 1 | 2013 | 15 | 0.440 |
Why?
|
Repressor Proteins | 1 | 2013 | 36 | 0.430 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2013 | 25 | 0.430 |
Why?
|
Reactive Oxygen Species | 3 | 2015 | 103 | 0.420 |
Why?
|
Neuroprotective Agents | 4 | 2021 | 51 | 0.400 |
Why?
|
Neurotrophin 3 | 2 | 2013 | 4 | 0.400 |
Why?
|
Antioxidants | 1 | 2012 | 57 | 0.390 |
Why?
|
DNA-Binding Proteins | 1 | 2013 | 249 | 0.380 |
Why?
|
NF-kappa B | 5 | 2012 | 96 | 0.380 |
Why?
|
Cells, Cultured | 9 | 2020 | 495 | 0.380 |
Why?
|
Peptides | 4 | 2018 | 104 | 0.370 |
Why?
|
Glial Cell Line-Derived Neurotrophic Factor | 3 | 2021 | 25 | 0.370 |
Why?
|
Multiple Sclerosis | 3 | 2023 | 93 | 0.360 |
Why?
|
Mice, Transgenic | 8 | 2020 | 217 | 0.360 |
Why?
|
Mice, Knockout | 4 | 2021 | 284 | 0.350 |
Why?
|
Chemokine CCL5 | 3 | 2019 | 14 | 0.330 |
Why?
|
Suppressor of Cytokine Signaling 3 Protein | 2 | 2019 | 7 | 0.310 |
Why?
|
Palmitic Acids | 2 | 2020 | 7 | 0.310 |
Why?
|
Myelin Basic Protein | 2 | 2009 | 22 | 0.310 |
Why?
|
Th2 Cells | 2 | 2007 | 15 | 0.310 |
Why?
|
Cinnamates | 2 | 2018 | 8 | 0.310 |
Why?
|
Integrins | 1 | 2007 | 11 | 0.290 |
Why?
|
Humans | 22 | 2023 | 25692 | 0.280 |
Why?
|
Protein Binding | 3 | 2020 | 116 | 0.280 |
Why?
|
Antibodies, Monoclonal | 2 | 2022 | 185 | 0.250 |
Why?
|
Male | 16 | 2020 | 13917 | 0.250 |
Why?
|
Nootropic Agents | 2 | 2016 | 14 | 0.250 |
Why?
|
Learning | 2 | 2016 | 67 | 0.250 |
Why?
|
Nitric Oxide Synthase Type II | 3 | 2013 | 66 | 0.230 |
Why?
|
Adaptive Immunity | 3 | 2022 | 18 | 0.220 |
Why?
|
PPAR-beta | 1 | 2023 | 11 | 0.220 |
Why?
|
Transcription Factors | 2 | 2021 | 158 | 0.210 |
Why?
|
Th17 Cells | 2 | 2020 | 25 | 0.210 |
Why?
|
Physical Conditioning, Animal | 1 | 2022 | 7 | 0.200 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2022 | 24 | 0.200 |
Why?
|
Triple Negative Breast Neoplasms | 1 | 2022 | 14 | 0.190 |
Why?
|
Plaque, Amyloid | 2 | 2019 | 138 | 0.190 |
Why?
|
MPTP Poisoning | 2 | 2019 | 13 | 0.180 |
Why?
|
Calcium | 2 | 2014 | 364 | 0.180 |
Why?
|
Inflammation Mediators | 4 | 2016 | 65 | 0.180 |
Why?
|
Dopamine | 3 | 2013 | 85 | 0.180 |
Why?
|
Receptors, Interleukin-12 | 1 | 2020 | 14 | 0.180 |
Why?
|
Cell Differentiation | 1 | 2021 | 127 | 0.170 |
Why?
|
Lipopolysaccharides | 3 | 2018 | 108 | 0.170 |
Why?
|
Hypolipidemic Agents | 2 | 2012 | 25 | 0.170 |
Why?
|
Chemokine CCL11 | 2 | 2017 | 9 | 0.170 |
Why?
|
Cell Line | 4 | 2019 | 268 | 0.160 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2019 | 12 | 0.160 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2019 | 5 | 0.160 |
Why?
|
Serine Proteases | 1 | 2019 | 5 | 0.160 |
Why?
|
Aminopeptidases | 1 | 2019 | 6 | 0.160 |
Why?
|
Butyrates | 1 | 2019 | 23 | 0.160 |
Why?
|
Plant Extracts | 2 | 2016 | 14 | 0.160 |
Why?
|
Rotenone | 1 | 2018 | 10 | 0.160 |
Why?
|
Corpus Striatum | 1 | 2019 | 60 | 0.160 |
Why?
|
Antiparkinson Agents | 1 | 2019 | 61 | 0.160 |
Why?
|
Lysosomes | 1 | 2018 | 21 | 0.160 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 30 | 0.160 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 100 | 0.150 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2018 | 13 | 0.150 |
Why?
|
Toll-Like Receptor 2 | 1 | 2018 | 28 | 0.150 |
Why?
|
Synapses | 2 | 2018 | 32 | 0.150 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 72 | 0.140 |
Why?
|
Sleep | 1 | 2021 | 316 | 0.140 |
Why?
|
Disease Progression | 4 | 2017 | 664 | 0.140 |
Why?
|
Female | 12 | 2022 | 14273 | 0.140 |
Why?
|
Maze Learning | 2 | 2015 | 15 | 0.140 |
Why?
|
Administration, Oral | 4 | 2020 | 103 | 0.140 |
Why?
|
Motor Activity | 4 | 2013 | 304 | 0.140 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 35 | 0.140 |
Why?
|
Ligands | 1 | 2016 | 37 | 0.140 |
Why?
|
STAT6 Transcription Factor | 1 | 2016 | 9 | 0.140 |
Why?
|
Food Preservatives | 1 | 2016 | 9 | 0.130 |
Why?
|
Down-Regulation | 2 | 2013 | 94 | 0.130 |
Why?
|
Models, Molecular | 1 | 2016 | 79 | 0.130 |
Why?
|
Macaca mulatta | 2 | 2013 | 60 | 0.130 |
Why?
|
Gastrointestinal Microbiome | 1 | 2018 | 167 | 0.130 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2016 | 29 | 0.130 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2016 | 5 | 0.130 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 325 | 0.130 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 86 | 0.130 |
Why?
|
rac GTP-Binding Proteins | 1 | 2015 | 4 | 0.120 |
Why?
|
Mice, Mutant Strains | 1 | 2015 | 24 | 0.120 |
Why?
|
Enzyme Activation | 2 | 2012 | 108 | 0.120 |
Why?
|
Cytokines | 2 | 2018 | 212 | 0.120 |
Why?
|
Fatty Acids | 1 | 2015 | 36 | 0.120 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 4 | 0.120 |
Why?
|
Nanotechnology | 1 | 2014 | 8 | 0.110 |
Why?
|
Castration | 1 | 2013 | 5 | 0.110 |
Why?
|
Memory Disorders | 1 | 2015 | 160 | 0.110 |
Why?
|
Transcription, Genetic | 1 | 2013 | 100 | 0.110 |
Why?
|
RNA, Messenger | 2 | 2018 | 284 | 0.100 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2012 | 2 | 0.100 |
Why?
|
Mevalonic Acid | 1 | 2012 | 7 | 0.100 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2012 | 14 | 0.100 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 140 | 0.090 |
Why?
|
Interleukin-23 | 2 | 2022 | 18 | 0.090 |
Why?
|
Interleukin-12 | 2 | 2022 | 33 | 0.090 |
Why?
|
Cerebral Cortex | 1 | 2012 | 155 | 0.090 |
Why?
|
Inflammation | 3 | 2018 | 261 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 20 | 0.080 |
Why?
|
Protein Multimerization | 1 | 2009 | 17 | 0.080 |
Why?
|
Adoptive Transfer | 1 | 2009 | 26 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2022 | 100 | 0.080 |
Why?
|
RNA, Double-Stranded | 1 | 2008 | 3 | 0.080 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2008 | 13 | 0.080 |
Why?
|
Hydrogen Peroxide | 1 | 2008 | 36 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 103 | 0.080 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2007 | 4 | 0.070 |
Why?
|
Mice, Inbred Strains | 1 | 2007 | 26 | 0.070 |
Why?
|
Cell Separation | 1 | 2007 | 28 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2007 | 31 | 0.070 |
Why?
|
Antibodies, Blocking | 2 | 2016 | 6 | 0.070 |
Why?
|
Cyclic GMP-Dependent Protein Kinases | 1 | 2006 | 2 | 0.070 |
Why?
|
Cyclic GMP | 1 | 2006 | 6 | 0.070 |
Why?
|
Oxazines | 1 | 2006 | 6 | 0.070 |
Why?
|
Oxadiazoles | 1 | 2006 | 8 | 0.070 |
Why?
|
Interferon-gamma | 2 | 2022 | 75 | 0.070 |
Why?
|
HIV-1 | 1 | 2008 | 221 | 0.060 |
Why?
|
Aging | 1 | 2013 | 1429 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2017 | 182 | 0.060 |
Why?
|
Valerates | 1 | 2023 | 3 | 0.050 |
Why?
|
Muscles | 1 | 2023 | 56 | 0.050 |
Why?
|
Proteomics | 1 | 2023 | 85 | 0.050 |
Why?
|
Neutralization Tests | 1 | 2022 | 10 | 0.050 |
Why?
|
Mice, Inbred NOD | 1 | 2022 | 25 | 0.050 |
Why?
|
Mice, SCID | 1 | 2022 | 37 | 0.050 |
Why?
|
Spleen | 1 | 2022 | 32 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2012 | 51 | 0.050 |
Why?
|
Immunotherapy | 1 | 2022 | 53 | 0.050 |
Why?
|
Macrophages | 1 | 2022 | 97 | 0.050 |
Why?
|
Cytochrome P-450 CYP2C8 Inhibitors | 1 | 2021 | 3 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2020 | 201 | 0.040 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 383 | 0.040 |
Why?
|
Pars Compacta | 1 | 2019 | 2 | 0.040 |
Why?
|
Plant Bark | 1 | 2019 | 3 | 0.040 |
Why?
|
Biotransformation | 1 | 2019 | 6 | 0.040 |
Why?
|
Fenofibrate | 1 | 2019 | 4 | 0.040 |
Why?
|
Rotarod Performance Test | 1 | 2019 | 8 | 0.040 |
Why?
|
Exploratory Behavior | 1 | 2019 | 9 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 31 | 0.040 |
Why?
|
Nerve Degeneration | 1 | 2019 | 41 | 0.040 |
Why?
|
Base Sequence | 1 | 2019 | 90 | 0.040 |
Why?
|
Lewy Bodies | 1 | 2020 | 171 | 0.040 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 7 | 0.040 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 2 | 2009 | 20 | 0.040 |
Why?
|
CREB-Binding Protein | 1 | 2018 | 6 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2018 | 38 | 0.040 |
Why?
|
Transfection | 1 | 2018 | 112 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2017 | 51 | 0.030 |
Why?
|
Myelin Proteolipid Protein | 1 | 2016 | 8 | 0.030 |
Why?
|
Aged | 3 | 2016 | 8501 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 23 | 0.030 |
Why?
|
Acute Disease | 1 | 2017 | 187 | 0.030 |
Why?
|
Amyloid beta-Peptides | 1 | 2018 | 315 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2016 | 4459 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2016 | 71 | 0.030 |
Why?
|
Adult | 2 | 2020 | 7336 | 0.030 |
Why?
|
Administration, Intranasal | 1 | 2015 | 27 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2015 | 93 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2014 | 13 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2014 | 37 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 123 | 0.030 |
Why?
|
Blotting, Western | 1 | 2014 | 140 | 0.030 |
Why?
|
Neostriatum | 1 | 2013 | 12 | 0.030 |
Why?
|
Testosterone | 1 | 2013 | 26 | 0.030 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2013 | 49 | 0.030 |
Why?
|
Formates | 1 | 2013 | 2 | 0.030 |
Why?
|
Cell Shape | 1 | 2013 | 8 | 0.030 |
Why?
|
Hormone Replacement Therapy | 1 | 2013 | 33 | 0.030 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2013 | 8 | 0.030 |
Why?
|
Primary Cell Culture | 1 | 2013 | 23 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2014 | 341 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 36 | 0.030 |
Why?
|
Fetus | 1 | 2013 | 37 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2013 | 42 | 0.030 |
Why?
|
Protein Kinase C | 1 | 2013 | 50 | 0.030 |
Why?
|
Phosphorylation | 1 | 2013 | 134 | 0.030 |
Why?
|
Middle Aged | 2 | 2016 | 8403 | 0.030 |
Why?
|
NF-KappaB Inhibitor alpha | 1 | 2012 | 5 | 0.030 |
Why?
|
I-kappa B Proteins | 1 | 2012 | 8 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2012 | 3 | 0.030 |
Why?
|
I-kappa B Kinase | 1 | 2012 | 4 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2012 | 11 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 32 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2012 | 41 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 137 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 169 | 0.020 |
Why?
|
Pravastatin | 1 | 2009 | 10 | 0.020 |
Why?
|
Neurotransmitter Agents | 1 | 2009 | 17 | 0.020 |
Why?
|
Cell Survival | 1 | 2009 | 110 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2009 | 13 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2009 | 88 | 0.020 |
Why?
|
Mesencephalon | 1 | 2007 | 19 | 0.020 |
Why?
|
Binding Sites | 1 | 2007 | 65 | 0.020 |
Why?
|
GATA3 Transcription Factor | 1 | 2007 | 4 | 0.020 |
Why?
|
Interleukin-4 | 1 | 2007 | 20 | 0.020 |
Why?
|
Th1 Cells | 1 | 2007 | 23 | 0.020 |
Why?
|
Cognitive Dysfunction | 1 | 2015 | 1017 | 0.020 |
Why?
|